Beth Harrison Meyer brings more than 25 years of experience across the medical device and consumer sectors, with leadership roles at Viant, Integer, and other global organizations. She leads brand, strategy, and growth initiatives at Aptyx, working closely with engineering and commercial teams to translate complex capabilities into clear market positioning.
She is known for translating complex engineering capabilities into clear, compelling strategies that drive growth and market impact. Beth is passionate about medtech innovation and is driven by a mission to help companies enhance patient lives through highly engineered products.
She holds an MBA from the University of California, Berkeley and a BA from Tulane University.
Catheter development challenges often appear during verification or scale-up, but their root causes frequently trace back to earlier engineering decisions. Architecture choices, material assumptions, tolerance stackups, and extrusion design all interact to shape device performance and manufacturability long before teams fully understand their impact.
This session explores the hidden complexity inside catheter systems and how early decisions, including those that define extrusion profiles, influence performance, manufacturability, and program timelines. Drawing on real-world experience, panelists will share practical approaches for aligning design intent with manufacturing reality to reduce risk and move programs from concept to clinic more efficiently.